- Home
- MASI vs CORT Comparison
MASI vs CORT Comparison
Compare MASI & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASI
- CORT
- Stock Information
- Founded
- MASI 1989
- CORT 1998
- Country
- MASI United States
- CORT United States
- Employees
- MASI N/A
- CORT N/A
- Industry
- MASI Medical/Dental Instruments
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- MASI Health Care
- CORT Health Care
- Exchange
- MASI Nasdaq
- CORT Nasdaq
- Market Cap
- MASI 8.1B
- CORT 7.6B
- IPO Year
- MASI 2007
- CORT N/A
- Fundamental
- Price
- MASI $143.23
- CORT $79.19
- Analyst Decision
- MASI Buy
- CORT Strong Buy
- Analyst Count
- MASI 6
- CORT 4
- Target Price
- MASI $194.60
- CORT $139.00
- AVG Volume (30 Days)
- MASI 608.9K
- CORT 675.5K
- Earning Date
- MASI 11-04-2025
- CORT 10-29-2025
- Dividend Yield
- MASI N/A
- CORT N/A
- EPS Growth
- MASI N/A
- CORT N/A
- EPS
- MASI N/A
- CORT 1.11
- Revenue
- MASI $2,153,800,000.00
- CORT $716,080,000.00
- Revenue This Year
- MASI N/A
- CORT $30.62
- Revenue Next Year
- MASI $7.80
- CORT $37.68
- P/E Ratio
- MASI N/A
- CORT $67.23
- Revenue Growth
- MASI 25.86
- CORT 25.71
- 52 Week Low
- MASI $111.03
- CORT $38.68
- 52 Week High
- MASI $194.88
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- MASI 43.03
- CORT 67.17
- Support Level
- MASI $140.11
- CORT $69.03
- Resistance Level
- MASI $148.95
- CORT $74.79
- Average True Range (ATR)
- MASI 3.95
- CORT 2.87
- MACD
- MASI 0.29
- CORT 0.67
- Stochastic Oscillator
- MASI 47.57
- CORT 98.12
About MASI Masimo Corporation
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.